Welcome to 30 Days of NEC Awareness
Kicking off Neuroendocrine Cancer Awareness Month with Ana's story and our mission for the next 30 days.
A daily November series breaking down high-grade neuroendocrine carcinoma, caregiver navigation, treatment paradigms, and the life of Ana Carolina Medina Castillo.
Kicking off Neuroendocrine Cancer Awareness Month with Ana's story and our mission for the next 30 days.
Understanding the biology of neuroendocrine neoplasms: comparing NETs and NECs, and why rarity complicates diagnosis.
The medical story behind the zebra mascot, and why neuroendocrine cancer patients proudly wear their stripes.
Recognizing the subtle, elusive signs of neuroendocrine neoplasms and the importance of listening to your body.
Recounting the earliest chapters of Ana's health battle, the subtle onset of symptoms, and the reality of rare illness.
The life-altering moment pathology confirmed high-grade neuroendocrine carcinoma and the whirlwind that followed.
Diving into tumor biology: why Ki-67 index, differentiation, and histology matter so much in neuroendocrine disease.
An overview of how high-grade neuroendocrine carcinoma is treated: frontline regimens, surgical considerations, and innovative trials.
Addressing the profound psychological weight of a rare cancer diagnosis on patients, spouses, and families.
On November 10, the global zebra community unites to raise our collective voice for early diagnosis and research.
Honoring the unsung heroes who walk beside cancer patients through every appointment, sleepless night, and challenge.
How neighbors, friends, and communities around the world lift families up during the darkest seasons of life.
Examining the clinical data, incidence rates, and survival statistics of neuroendocrine neoplasms.
Highlighting cutting-edge scientific innovations, novel therapies, and the future of neuroendocrine carcinoma treatment.
Reflecting on fifteen days of shared stories, honest truths, and the collective momentum of our awareness campaign.
Practical guidance for managing medical records, insurance challenges, and multi-specialty care teams.
Shedding light on the staggering financial burdens of rare cancer care and available resources for families.
Why seeking a second pathology review and specialized oncology consultation is essential for rare cancer patients.
Demystifying clinical trials: how trials work, common myths, and how to find research studies for NEC.
Empowering patients and caregivers to ask hard questions, assert their needs, and take an active role in care.
How the Neuroendocrine Tumor Research Foundation accelerates scientific discovery and why our memorial fundraiser matters.
Remembering Ana's extraordinary ability to find joy and peace, even amidst the most difficult hospital stays.
Examining the unique medical and social hurdles faced by adolescent and young adult (AYA) patients with rare cancers.
Understanding the complex realities of life during and after cancer treatment: chronic side effects and scan surveillance.
Guidance on approaching conversations about serious illness, hospital stays, and grief with young children.
How the pain of losing Ana became the foundation for Ana's Legacy: honoring her values through community and action.
Bringing community together on Ana's birthday to restore local green belts and plant native Texas bluebonnets.
A comprehensive directory of patient support networks, financial aid, and specialized clinical resources for NEC.
Tangible, impactful ways you can support rare cancer research, advocate for patients, and carry Ana's legacy forward.
Concluding our 30-day blog series with heartfelt gratitude from Josue and the Negron family, and looking ahead.
Neuroendocrine cancer research receives only a fraction of national oncology funding. Consider supporting the Neuroendocrine Tumor Research Foundation (NETRF) in Ana's memory.